市场调查报告书
商品编码
1370477
多毛症市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Hirsutism Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球多毛症市场规模达28亿美元。展望未来,IMARC集团预计到2028年市场规模将达到43亿美元,2023-2028年复合年增长率(CAGR)为7.2%。
多毛症是一种影响女性的疾病,会导致特定身体部位的毛髮过度生长,包括脸部、颈部、胸部、腹部、下背部和大腿。它通常是由于雄性激素(称为雄激素)过多和某些医疗状况(例如多囊性卵巢综合症(PCOS))造成的。多毛症可以透过药物、局部除毛产品或透过电解、雷射疗法和除毛设备等手术来治疗。秃头、痤疮、声音低沉、髮际线后退、乳房缩小和肌肉质量增加是多毛症的一些常见症状。
全球多毛症病例数量的不断增加,尤其是老年女性,正在为市场创造积极的前景。多毛症通常发生在停经后妇女身上,由肾上腺或卵巢肿瘤分泌雄性激素所致。此外,由于女性体毛过多而导致身体疾病的发生率上升,可能会导緻美容和心理问题,这反过来又有利于市场的成长。此外,医疗保健专业人员和活动人士正在向大众宣传多毛症的可用治疗方法,这是另一个生长诱导因素。除此之外,对需要多次治疗的雷射和强烈脉衝光(IPL)设备除毛手术的需求不断增加,这也推动了市场的成长。与此一致,製造商正在专注于开发基于二甲双胍的外用疗法,作为多囊性卵巢症候群女性中度至重度多毛症的有效治疗方法,这正在推动市场成长。此外,由于职业女性人口不断增长,个人护理支出不断增加,对市场成长产生了积极影响。其他因素,包括广泛的研发 (R&D) 活动、雷射除毛技术的接受度不断提高以及 PCOS 的日益流行,预计将推动市场成长。
The global hirsutism market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.
Hirsutism is a condition affecting females that cause excess hair growth on specific body parts, including the face, neck, chest, stomach, lower back, and thighs. It commonly occurs due to excess male hormones, called androgens, and certain medical conditions, such as polycystic ovary syndrome (PCOS). Hirsutism can be treated with medication, topical hair removal products, or through procedures, such as electrolysis, laser therapy, and hair removal equipment. Balding, acne, deepening voice, receding hairline, decreased breast size, and increased muscle mass are some common symptoms of hirsutism.
The increasing number of hirsutism cases, especially in older women, across the globe is creating a positive outlook for the market. Hirsutism commonly occurs in postmenopausal women by androgen secretion from adrenal or ovarian tumors. Additionally, the rising incidences of bodily disorders due to the presence of excessive body hair in women can cause cosmetic and psychological problems, which, in turn, is favoring the market growth. Moreover, healthcare professionals and activists are sensitizing the masses about available treatments for hirsutism, which is acting as another growth-inducing factor. Apart from this, the increasing demand for hair removal procedures with lasers and intense pulsed light (IPL) equipment requiring multiple treatment sessions is providing an impetus to the market growth. In line with this, manufacturers are focusing on developing topical metformin-based therapeutics that act as an effective treatment for moderate to severe hirsutism in women with PCOS, which is propelling the market growth. Furthermore, the increasing personal care expenditure due to the growing working women population is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, growing acceptance of laser hair removal techniques, and the increasing prevalence of PCOS, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hirsutism market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapy type, products and end user.
Procedures
Medication
Hair Removal Equipment
Topical Hair Removal Products
Others
Hospitals
Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd (Sisram Medical Ltd), Alpaya Dermaceuticals, Bayer AG, Cutera Inc., Cynosure Inc., Lumenis Inc., Nisim International Inc. and Sciton Inc.